Join to View Full Profile
500 Parnassus AveSan Francisco, CA 94143
Phone+1 415-476-9035
Dr. Legrand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Paris VII Faculty of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2019 - 2026
Clinical Trials
- Cardiovascular Biomarkers and Lung Edema in Severe Burns Patients Start of enrollment: 2017 Aug 06
Roles: Contact
- Timing of Surgery And Outcome in Burn Patients ( EARLYBURN ) Start of enrollment: 2016 Dec 25
Roles: Principal Investigator, Contact
- Impact of Renin-Angiotensin System Inhibitors Continuation on Outcome After Major Surgery Start of enrollment: 2018 Feb 06
Roles: Contact
Publications & Presentations
PubMed
- Alterations in the renin-angiotensin system during septic shock.Camille Benaroua, Fabrizio Pucci, Marianne Rooman, Adrien Picod, Raphaël Favory
Annals of Intensive Care. 2025-03-24 - Advancing surgical outcomes through cardiovascular biomarker sub-phenotyping.Bruno Garcia, Ashish K Khanna, Matthieu Legrand
British Journal of Anaesthesia. 2025-03-14 - Management of renin-angiotensin system inhibitors prior to major surgery: insights from the STOP-or-NOT trial.Matthieu Legrand, Etienne Gayat
British Journal of Anaesthesia. 2025-03-01
Press Mentions
Studies Unravel 3 Common Medical PracticesSeptember 16th, 2024- Three Medical Practices That Older Patients Should QuestionSeptember 14th, 2024
- Pause or Keep RAS Inhibitors Before Surgery? Take Your PickAugust 31st, 2024
- Join now to see all
Grant Support
- The choice of vasopressor to prevent postoperative acute kidney injury after major non-cardiac surgery: a multicenter pragmatic cluster cross-over randomized trial (the VEGA-2 trial)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Identification of sub-phenotypes of severely ill burn patients and risk for secondary sepsis: SEPSISBURNUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2027
- Identification of sub-phenotypes of severely ill burn patients and risk for secondary sepsis: SEPSISBURNUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
